Concepedia

Melissa P. Andrews

MP

Statistics

Publications

5

Citations

146

H-Index

5

Active since

2009

Affiliations

Pfizer (United States)(Current)

Melissa P. Andrews is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2009–2013

5

Publications

5

The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents

Michael P. DeNinno, Melissa P. Andrews, Andrew Bell et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 45 citations · Full text

, , +8

Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119

Etzer Darout, Ralph P. Robinson, Kim F. McClure et al. · Journal of Medicinal Chemistry · 2012 · 31 citations · Full text

, , +15

1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability

Michael P. DeNinno, Stephen W. Wright, Michael Visser et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

, , +7

Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core

Robert L. Dow, Melissa P. Andrews, Gary E. Aspnes et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 22 citations · Full text

, , +11

Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor

Robert L. Dow, Melissa P. Andrews, Jiancheng Li et al. · Bioorganic & Medicinal Chemistry · 2013 · 21 citations · Full text

, , +14

1–5 of 5